Ravi Sahu | Pharmacology | Best Researcher Award

Best Researcher Award

Ravi Sahu – Wright State University Boonshoft School of Medicine

Ravi Sahu
Affiliation Wright State University Boonshoft School of Medicine
Country United States
Scopus ID 36833607800
Documents 1076
Citations 1372
h-index 23
Subject Area Pharmacology
Event World Top Scientist Awards
ORCID 0000-0003-3857-9073

Ravi Sahu is a pharmacology researcher associated with Wright State University Boonshoft School of Medicine in the United States. His research profile demonstrates a consistent contribution to biomedical sciences, particularly in cancer pharmacology and molecular therapeutics. The recognition under the Best Researcher Award category reflects scholarly output, citation impact, and involvement in global research collaborations. His work has contributed to advancing understanding in cancer biology, immunotherapy, and drug repurposing strategies [1].

Abstract

This article presents an academic overview of Ravi Sahu, emphasizing his scholarly contributions in pharmacology and cancer research. His work spans experimental therapeutics, immunological pathways, and drug repurposing strategies. The evaluation is based on bibliometric indicators including citation count, h-index, and research output. The profile aligns with international standards used in academic recognition systems [2].

Keywords

Pharmacology, Cancer Research, Immunotherapy, Drug Repurposing, Molecular Biology, Oncology, Research Metrics.

Introduction

The field of pharmacology has evolved significantly with the integration of molecular biology and translational medicine. Researchers such as Ravi Sahu have contributed to bridging laboratory findings with clinical applications. His research focuses on understanding cellular signaling pathways and developing therapeutic interventions. These efforts contribute to improved treatment strategies in oncology [3].

Research Profile

The research profile of Ravi Sahu indicates substantial scholarly output with over a thousand indexed documents and a growing citation base. His work is indexed in major academic databases including Scopus and ORCID. The profile reflects interdisciplinary collaboration and sustained research productivity. These indicators are commonly used to assess academic performance globally [1].

Research Contributions

Ravi Sahu has contributed to multiple areas including cancer therapeutics, platelet-activating factor signaling, and immune checkpoint research. His publications explore mechanisms of tumor progression and therapeutic resistance. The research also includes investigations into repurposed drugs such as metformin and itraconazole. These contributions enhance understanding of treatment optimization strategies [4].

Publications

The publication record includes peer-reviewed journal articles across high-impact biomedical journals. Notable works include studies on lung cancer therapies, melanoma treatment, and molecular signaling pathways. The research demonstrates both experimental and review-based scholarship. These publications contribute to advancing scientific knowledge and clinical practices [5].

Research Impact

The research impact of Ravi Sahu is reflected through citation metrics and academic collaborations. His work has been cited in multiple interdisciplinary studies, indicating relevance across scientific domains. The h-index value highlights consistent scholarly influence. Such metrics are critical in evaluating research visibility and academic significance [2].

Award Suitability

The Best Researcher Award recognizes individuals demonstrating excellence in scientific research and innovation. Ravi Sahu’s academic record meets key criteria including publication output, citation impact, and subject expertise. His involvement in international research initiatives further strengthens his eligibility. These factors collectively support recognition at global scientific platforms [3].

Conclusion

Ravi Sahu’s contributions to pharmacology and cancer research demonstrate sustained academic excellence. His work integrates molecular insights with therapeutic applications, contributing to advancements in biomedical science. The recognition under the Best Researcher Award highlights the significance of his scholarly achievements. Continued research efforts are expected to further enhance his impact in the scientific community [4].

References

  1. Elsevier. (n.d.). Scopus author details: Ravi Sahu, Author ID 36833607800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36833607800
  2. Sahu, R. P., Zonfa, C. E., & Thyagarajan, A. (2026). Repurposing itraconazole in combination with chemotherapy and immune checkpoint inhibitor for cancer. Medical Sciences, 14(1), 55.
    https://doi.org/10.3390/medsci14010055

  3. Thyagarajan, A., Gajjar, V., & Sahu, R. P. (2025). Are metformin-based combination approaches beneficial for non-small cell lung cancer: Evidence from experimental and clinical studies. Military Medical Research, 12, 61.
    https://doi.org/10.1186/s40779-025-00649-5

  4. Sahu, R. P., et al. (2025). Platelet-activating factor signaling in cancer. Journal of Applied Toxicology. Advance online publication. https://doi.org/10.1002/jat.4770

  5. Sahu, R. P., et al. (2023). Melatonin in melanoma treatment. Medical Sciences, 11(1), 9.

    https://doi.org/10.3390/medsci11010009

     

Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy  | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Lichun Zhao | Pharmacology | Best Researcher Award

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Prof. Dr. Lichun Zhao is a distinguished researcher and academic leader specializing in trace elements, traditional medicine, and health development. He serves as a doctoral supervisor, director of research centers and laboratories, and executive editor in chief of Trace Elements and Health Research, while holding key leadership roles in national and regional scientific associations. Recognized with numerous prestigious honors, he has successfully led major national and international projects, secured innovative medicine approvals, and contributed to product development. His prolific output includes over two hundred publications, highly cited SCI papers, multiple monographs, patents, and software copyrights, reflecting both scientific innovation and practical application. He has also been honored with multiple science and technology awards, underscoring the impact of his research. Committed to advancing both scholarship and healthcare, Prof. Zhao exemplifies excellence in integrating academic research, innovation, and leadership, making him a highly influential figure in his field.

Professional Profile 

Scopus Profile

Education

Prof. Dr. Lichun Zhao earned his Ph.D. in a field closely related to trace elements, medicine, and health sciences, building a solid academic foundation for his future research. Following his doctoral studies, he pursued postdoctoral training at Hong Kong Baptist University, where he broadened his expertise and gained valuable international research exposure. His educational journey reflects a strong emphasis on both traditional medicine and modern scientific approaches, allowing him to bridge classical knowledge with contemporary methodologies. By combining advanced laboratory techniques with deep understanding of traditional Chinese medicine, he has cultivated a unique academic profile that continues to drive his research innovations. His educational background not only prepared him for his roles in academia and research but also established his credentials as a mentor for doctoral students and an authoritative voice in integrating traditional practices with modern scientific frameworks.

Experience

Prof. Dr. Zhao has accumulated extensive academic and professional experience through his multiple leadership roles and active engagement in research. He serves as a doctoral supervisor, guiding and mentoring the next generation of researchers, while simultaneously holding positions as director of the Research Department and the Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Beyond his university roles, he directs major laboratories in Guizhou and Guangxi, leading innovation in endangered medicinal resources. His editorial work as executive editor in chief of Trace Elements and Health Research further demonstrates his commitment to advancing scholarly communication. In addition, he actively contributes to national scientific development as a project evaluation expert for significant research foundations and technology awards. Through these experiences, Prof. Zhao has built a career that integrates research, leadership, and service, positioning him as both a pioneering scientist and an influential academic administrator.

Research Focus

The core of Prof. Dr. Zhao’s research lies in the intersection of trace elements, traditional Chinese medicine, and health development. His work emphasizes the exploration of medicinal resources, the development of innovative treatments, and the application of modern scientific tools such as big data and artificial intelligence to healthcare research. He has led numerous national and international projects aimed at advancing understanding of trace elements in human health, as well as developing standardized, evidence-based approaches to traditional medicine. A significant part of his focus is dedicated to the preservation and innovation of endangered medicinal materials, ensuring sustainable resources for future therapeutic use. His achievements include obtaining clinical approvals for new medicine, producing certified products, and publishing influential studies recognized globally. Prof. Zhao’s research is notable for its ability to combine ancient knowledge with modern technology, creating novel solutions that enhance healthcare outcomes and scientific advancement.

Award and Honor

Prof. Dr. Zhao has been widely recognized for his scientific excellence and leadership with numerous national and regional awards. He was the first to receive the prestigious National Youth Qihuang Scholar distinction and has been selected for Hong Kong’s “Excellent Talent Plan.” His honors include recognition as an Outstanding Scholar in Guangxi, a leader of high-level innovation teams, and a candidate in talent development initiatives such as the “Ten Hundred Thousand Talents Project.” He has also received the Guangxi Youth Science and Technology Award and multiple provincial science and technology prizes, including the Guangxi Science and Technology Progress Award and the Jilin Province Natural Science Award. His contributions have further been acknowledged through the China Industry-University-Research Cooperation Innovation Award. Collectively, these distinctions highlight not only his research excellence but also his role as an innovator and leader whose work has had profound impact in both academic and applied scientific fields.

Publications Top Notes

  • Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Bacteriostatic activity and mechanism of minerals containing rubidium
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 3

  • Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Authors: Zhao Lichun et al.
    Year: 2025
    Citations: 13

  • Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Authors: Zhao Lichun et al.
    Year: 2025

  • Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Authors: Zhao Lichun et al.
    Year: 2024
    Citations: 22

Conclusion

The reviewed publications of Prof. Dr. Lichun Zhao reflect a strong and diverse research portfolio spanning trace elements, traditional Chinese medicine, cancer biology, inflammatory diseases, and innovative material science applications. His works demonstrate both depth in exploring mechanisms of disease and breadth in applying interdisciplinary approaches to health solutions. The range of topics covered—from Alzheimer’s disease and rhinosinusitis to breast cancer and ulcerative colitis—highlights his ability to integrate traditional medicine knowledge with modern biomedical and technological advances. The citations already received for some of these recent studies, particularly in high-impact areas such as cancer research and therapeutic innovations, indicate growing recognition of his contributions within the scientific community. Overall, his research achievements showcase academic rigor, innovation, and practical significance, further strengthening his candidacy for recognition through prestigious research awards.